To access this element change to forms mode OFF
Grant Award View - GA40797
PETReA: Phase 3 evaluation of PET-guided, Response-Adapted therapy in...
GA ID:
GA40797
Agency:
Department of Health and Aged Care
Approval Date:
29-Mar-2019
Publish Date:
26-Apr-2019
Category:
Medical Research
Grant Term:
1-Apr-2019 to 31-Mar-2024
Value (AUD):
$787,068.85
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 18/19 1.1 Health and Medical Research
Grant Program:
2018_MRFF Rare Cancers Rare Diseases, Unmet Need_commencing_2018
Grant Activity:
PETReA: Phase 3 evaluation of PET-guided, Response-Adapted therapy in patients with previously untreated, high tumour burden follicular lymphoma.
Purpose:
The phase 3 randomised controlled trial aims to improve the outcome of Follicular Lymphoma patients who remain PET positive after initial immunochemotherapy (who have demonstrated to have a poor outcome), and minimise further treatment for good prognosis patients who become PET negative. If the study can confirm the benefit of a PET response adapted approach, it will establish a new standard of care for follicular lymphoma globally.
GO ID:
GO Title:
Medical Research Future Fund Clinical Trials Activity – Rare Cancers, Rare Diseases and Unmet Need Grant Opportunity
Internal Reference ID:
MRF1170260
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Sydney
Recipient ABN:
15 211 513 464
Grant Recipient Location
Suburb:
Camperdown
Town/City:
Camperdown
Postcode:
2050
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, NSW, VIC, WA, QLD, TAS
Postcode:
Multiple
Country:
AUSTRALIA